Three gold stocks: Which one should you buy?At long last, it's Friday, and a turbulent week of selling, buying, and even more selling is at an end.Investors seem exhausted by the roller-coaster week. Major market indices are slightly in the green as traders pause in relief, unfazed by the latest economic news that China is retaliating from the most recent U.S. tariffs hike on Chinese exports (to 145%) by raising its own tariff on U.S. exports to 125%. Gold stocks, meanwhile, are looking like one bright pock ...

Newmont Corporation (NEM) shares rallied 8.4% in the last trading session to close at $48.75. This move can be attributable to notable volume with a higher number of shares being traded than in a typical session. This compares to the stock's 3.6% gain over the past four weeks.NEM's shares rallied on a surge in gold prices on safe-haven demand after President Trump hiked tariffs on China to 125%, stoking fears of deeper trade disruptions. This gold and copper miner is expected to post quarterly earnings of $ ...

Core Viewpoint - Gold stocks are gaining traction as a hedge against market volatility caused by ongoing tariff disputes, with significant price increases observed in several gold mining companies [1][3][4]. Gold Market Performance - Gold prices increased by over 3% as investors sought safe-haven assets amid stock market sell-offs triggered by tariffs [3][4]. - Gold stocks, particularly those of companies with strong operational performances, have rallied due to the direct impact of rising gold prices on their financials [5]. Company Highlights - Newmont Corporation, the world's second-largest gold company, saw its shares rise by 8.8% with a market capitalization of $52.2 billion [2]. - Harmony Gold reported a 19% increase in revenue and a 33% surge in net income, despite a 4% drop in production, with cash flow from operations increasing by 46% year-over-year [6]. - AngloGold Ashanti's revenue jumped 26% in 2024, leading to a net profit of $1 billion compared to a net loss of $222 million in 2023, with a dividend yield of 4.1% [7]. - Iamgold Corp experienced a 43% increase in gold production and a 65% rise in revenue to $1.6 billion in 2024, projecting further growth in 2025 [10]. - Newmont Mining reported a net income of $3.4 billion in 2024, recovering from a net loss of $2.5 billion in 2023, and generated $6.3 billion in cash flow from operations [11]. Future Outlook - The year 2025 is anticipated to be significant for gold mining companies, with expectations of continued growth driven by rising gold prices amid ongoing trade tensions [12].

Core Viewpoint - Newmont Corporation (NEM) and Barrick Gold Corporation (GOLD) are two leading gold mining companies, both benefiting from soaring gold prices due to global economic uncertainties and trade tensions, making them relevant for investors in the precious metals sector [1][2]. Group 1: Newmont Corporation (NEM) - Newmont is focused on growth projects, including the Tanami Expansion 2 in Australia and the Ahafo North expansion in Ghana, which are expected to enhance production capacity and extend mine life [4]. - The acquisition of Newcrest Mining Limited has created a robust portfolio, with expected annual run-rate synergies of $500 million, enhancing shareholder value [5]. - Newmont's attributable gold production increased by approximately 9% year over year in Q4 2024, with divestitures expected to yield total gross proceeds of $4.3 billion [6]. - The company reported liquidity of $7.7 billion at the end of 2024, with operating cash flow from continuing operations rising to $6.3 billion, up from $2.8 billion in 2023 [7]. - Newmont returned $1.1 billion to shareholders through dividends and share repurchases in 2024, with a dividend yield of 2.3% and a payout ratio of 29% [8]. - However, Newmont faces challenges with rising production costs, with gold costs applicable to sales increasing by roughly 7% year over year in 2024, and all-in-sustaining costs projected to rise to $1,630 per ounce in 2025 [9]. Group 2: Barrick Gold Corporation (GOLD) - Barrick has made a strong recovery in 2024, driven by rising gold prices, despite facing high production costs and operational issues in the previous year [11]. - The company is advancing key growth projects, including Goldrush and the Pueblo Viejo plant expansion, which are expected to significantly boost production [12]. - Barrick reported cash and cash equivalents of approximately $4.1 billion at the end of 2024, with operating cash flows increasing by 20% year over year to around $4.5 billion [13]. - The company returned about $1.2 billion to shareholders in 2024, with a dividend yield of 2.3% and a payout ratio of 31% [13]. - Barrick's cash costs per ounce of gold and all-in-sustaining costs increased by around 11% year over year in 2024, with projections for 2025 indicating further increases [14]. Group 3: Price Performance and Valuation - Year to date, NEM stock has increased by 18.7%, while GOLD stock has gained 14%, compared to the Zacks Mining – Gold industry's increase of 24.9% [15]. - NEM is trading at a forward 12-month earnings multiple of 13.62X, representing a 12% discount to the industry average of 15.55X [16]. - The Zacks Consensus Estimate for NEM's 2025 sales and EPS indicates declines of 3.6% and 7.2%, respectively, while GOLD's estimates suggest growth of 4.7% and 10.3% [18][21]. - Barrick appears more attractively priced with a forward earnings multiple of 12.44X, lower than its five-year median and below the industry average [19]. Group 4: Investment Outlook - Both NEM and GOLD are well-positioned to benefit from the surge in gold prices, demonstrating strong financial performance and commitment to shareholder returns [24]. - Barrick may have a slight edge over Newmont due to its more attractive valuation and positive growth projections, suggesting better investment prospects in the current market environment [25].

Market Overview - As the first quarter of 2025 concluded, initial market optimism faded due to trade war fears and economic uncertainty [1] - No S&P 500 sector achieved double-digit gains, with energy leading at an 8.08% rise [2] Top Performers - CVS Health emerged as the top-performing S&P 500 stock, surging 52.8% following stronger-than-expected fourth-quarter earnings [3] - Philip Morris International followed with a 33.1% gain, driven by growth in its smoke-free product segment and high dividend appeal [5] - Newmont Corporation rose 30.5% due to increasing gold prices amid market uncertainty [6] - AT&T Inc. gained nearly 26%, benefiting from its domestic business model that insulated it from tariff volatility [7] Financial Highlights - CVS Health exceeded Wall Street estimates on revenue and adjusted earnings per share, trading at $66.79 [4] - Philip Morris International offers a quarterly dividend of $1.35 per share, with shares trading at $161.75 [5] - Newmont Corporation's stock is trading at $47.60 [6] - AT&T's stock is currently at $28.73, favored by income-focused investors due to its strong dividend yield [7]

NEW YORK, April 1, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Newmont Corporation ("Newmont" or the "Company") (NYSE: NEM) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Newmont investors who were adversely affected by alleged securities fraud between February 22, 2024 and October 23, 2024. Follow the link below to get more information and be contacted by a member of our team: https://zlk.com/pslra-1/newmont-corporation-lawsuit- ...

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/. WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Newmont Corporation (NYSE: NEM) between February 22, 2024 and October 23, 2024, inclusive (the "Class Period"), of the important April 1, 2025 lead plaintiff deadline. SO WHAT: If you purchased Newmont securities during the Class Per ...

Group 1: Market Overview - The end of Q1 2025 is approaching, with many S&P 500 stocks showing strong year-to-date performances despite recent volatility from tariff discussions and economic developments [1] - Notable top performers include Philip Morris (PM), CVS Health (CVS), and Newmont (NEM) [1] Group 2: Philip Morris (PM) - Philip Morris has reported better-than-expected results, with EPS growing by 14% and sales increasing by 7% [2] - Smoke-free products exceeded 40 billion units for the first time in FY24, with net revenues for the Smoke-free Business (SFB) rising by 14.2% and gross profit increasing by 18.7% [3] - The company offers a high dividend yield of 3.5% annually and is recognized as a Dividend King [3] Group 3: CVS Health (CVS) - CVS shares have rebounded significantly in 2025, up 50% year-to-date, ending a prolonged decline [5] - The company experienced a 4% year-over-year sales increase, although EPS declined by 44% [5] - Analysts are optimistic about upcoming quarterly results, with a consensus EPS estimate of $1.62 per share, reflecting a 12% increase and 23% year-over-year growth [7] Group 4: Newmont (NEM) - Newmont, a major gold producer, has seen its stock rise nearly 30% year-to-date, driven by a surge in gold prices [8] - The average gold price per ounce reached $2,643, up from $2,004 in the same period last year [9] - The company reported a record free cash flow of $1.6 billion, enhancing its ability to pay dividends and reduce debt [9][13]

NEW YORK, March 31, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Newmont Corporation (NYSE: NEM). Shareholders who purchased shares of NEM during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CLASS PERIOD: February 22, 2024 to October 23, 2024 ALLEGATIONS: According to the complaint, on October 23, 2024, Newmont published a press rele ...

Core Viewpoint - Newmont Corporation is facing a class action securities lawsuit due to alleged securities fraud that affected investors between February 22, 2024, and October 23, 2024 [1] Group 1: Lawsuit Details - The lawsuit was initiated following Newmont's announcement on October 23, 2024, which disclosed disappointing EBITDA for Q3 2024, alongside decreases in production and increases in operating costs [2] - Newmont's stock price dropped significantly from $57.74 per share on October 23, 2024, to $49.25 per share on October 24, 2024, reflecting investor reaction to the negative news [2] Group 2: Investor Participation - Investors who suffered losses during the specified timeframe have until April 1, 2025, to request appointment as lead plaintiff, although participation in any recovery does not require serving as a lead plaintiff [3] - Class members may be entitled to compensation without any out-of-pocket costs or fees, ensuring no financial obligation to participate [3] Group 3: Legal Firm Background - Levi & Korsinsky, LLP has a strong track record, having secured hundreds of millions of dollars for shareholders and being recognized as one of the top securities litigation firms in the United States for seven consecutive years [4]